Twitter
Advertisement

Govt to carry out study on drug-resistant superbug

Faced with persistent reports of a drug-resistant superbug in the country, the health ministry is carrying out a study to check the presence of any such bacteria.

Latest News
article-main
FacebookTwitterWhatsappLinkedin

Faced with persistent reports of a drug-resistant superbug in the country, the health ministry is carrying out a study to check the presence of any such bacteria.

The study would be jointly conducted by the Union health ministry and a special task force, which has been set up for the purpose. Project coordinator and the surveillance team set up for the purpose in the selected tertiary care hospitals will implement the surveillance of antimicrobials.

The data generated will be used for intervention studies for rational use of antibiotics, a senior health ministry official said.

The first phase of the study will be conducted in three tertiary care hospitals under central government in Delhi. It will focus on studying the trends in antibiotic use in these hospitals of Delhi.

Later on, the study would also include peripheral health facilities as well as pharmacies to obtain community based data on antimicrobial usage.

In the study, auditing of the pharmacies in the hospital, prescription of the practitioner as well as the pharmacies in the cities, districts and villages should be audited through a random selection basis.

The study will have a multi-disciplinary advisory committee of experts who will meet at regular intervals and their inputs will be helpful for implementation of the study.

The hospitals where the study would be started are Sucheta Kriplani Hospital, New Delhi, RML Hospital, New Delhi and Safdarjung Hospital, New Delhi.

The first phase of the study would be concluded in approximately three months but will be continued as surveillance. The fourth month data will be analysed for overall consumption and trends of antibiotic use.

The data collection would include consumption of antibiotics in various departments, the medical store and prescription data.

The total consumption of all antibiotics used or consumed will be collected every month from in-patients issued to each department.

Out-patients will be screened through exit interviews, which would be carried out at the pharmacy of the public hospital, and for each special clinic operating in the public hospitals.

For private hospitals, the data collectors will do exit interview for each speciality in their OPD days and time.

Exit interviews would also be done of patients receiving any antibiotic at the chosen hospital, department or special clinic.

A total of 30 exit interviews per month from each special clinic would be done and from general pharmacy 600 exit interviews will be done.

The data would be entered through a sophisticated software programme which will be developed for the purpose, the official said.

The data obtained will be analysed to show monthly patterns of use and consumption of various group of antibiotic in all three public hospitals. It will be compared between 34 hospitals as well as between various departments using different methodologies following which a detailed secondary analysis will be done to find trends of antibiotic use.

The results will be disseminated at the end of four months for all stakeholders and participants of the study.

The decision to conduct such a study comes close on the heels of international health journal Lancet claiming that drug-resistant superbug NDM-I has been found in the capital's public water supply.

Find your daily dose of news & explainers in your WhatsApp. Stay updated, Stay informed-  Follow DNA on WhatsApp.
Advertisement

Live tv

Advertisement
Advertisement